K. Tabuchi et al., Ischemia-reperfusion injury of the cochlea: effects of an iron chelator and nitric oxide synthase inhibitors, HEARING RES, 160(1-2), 2001, pp. 31-36
Release of free iron from cellular stores and activation of nitric oxide sy
nthase (NOS) has been implicated in a wide variety of cochlear injuries. In
order to evaluate the effects of deferoxamine (a iron chelator), 3-bromo-7
-nitroindazole (a relatively selective neuronal NOS (nNOS) inhibitor) or am
inoguanidine (a relatively selective inducible NOS (iNOS) inhibitor) on the
post-ischemic cochlear dysfunction, albino guinea pigs were subjected to 3
0 min ischemia, and the threshold shifts of the compound action potential (
CAP) from pre-ischemic values were compared with those of control animals 4
h after the onset of reperfusion. A statistically significant reduction in
the post-ischemic CAP threshold shift was observed in the animals treated
with deferoxamine or 3-bromo-7-nitroindazole. However, aminoguanidine did n
ot affect the post-ischemic CAP threshold shift. These results suggest that
free iron and nNOS play deleterious roles in the cochlear injury induced b
y transient ischemia. (C) 2001 Elsevier Science B.V. All rights reserved.